Translations

Mr. Hamilton is one of the world’s most prolific inventors with over 1,060 patents, standing just behind Thomas Edison. He has spent nearly 30 years at Fortune 50 healthcare companies and is an expert in focused ultrasound, generative AI, IP strategy, and healthcare innovation. 

Hamilton was formerly a Master Inventor at IBM, where at one point he was the top inventor in company history. Before this, he was Vice President and Senior Distinguished Engineer at Optum, where he was deeply involved in UnitedHealth Group's strategic initiatives in machine learning, genomics, IoT, and cybersecurity to help people live healthier lives and improve the healthcare system. 

Most recently, Mr. Hamilton has joined the Focused Ultrasound Foundation as Managing Director and Chief Technology Officer, where he continues to push the boundaries of innovation in non-invasive therapeutic technologies. If you’re curious about the future of healthcare and technology, this episode provides valuable insights from one of the greatest minds in the field. 

Hosted by Justin Lumpkin.

CvilleBioHub accelerates the development and commercialization of innovative biotech and medtech solutions that improve human health and well-being by connecting entrepreneurs, scientists and investors, providing access to funding and resources, and advocating for policies that support life sciences.

Dr. Grammer is a visionary biotech executive and NIH-trained scientist-entrepreneur, specializing in immunology, genomics, pharmacology, and machine learning/predictive AI. She has successfully turned her research into a precision health company that delivers groundbreaking prognostic tests and biomarker monitoring for patients and pharmaceutical companies. This year, her company, AMPEL BioSolutions, launched the LuGENE® blood test, a first-of-its-kind tool that predicts lupus flares and identifies abnormal drug targets, drawing attention from the Lupus Foundation of America, Lupus News Today, and various business organizations. The test has been featured by prominent outlets including NPR RadioIQ, GenomeWeb, CBS19, Helio, and Scripps News Network.   

Hosted by Justin Lumpkin and Ben Benson.

CvilleBioHub accelerates the development and commercialization of innovative biotech and medtech solutions that improve human health and well-being by connecting entrepreneurs, scientists and investors, providing access to funding and resources, and advocating for policies that support life sciences.

Kate Byrne is the Chief Growth Officer at Goodlight Capital, where she is pioneering a more equitable future in the VC landscape. Her commitment to social change extends beyond just venture capital, as she has also led other organizations that are dedicated to effective altruism, like SOCAP Global and the Tides Foundation. 

Kate has been at the forefront of leveraging technology and media to make a positive impact in the world, as she has been honored as one of the 40 Most Influential People in Media. She has held executive positions across renowned organizations such as the Katapult Foundation, Entrepreneur Media, and more. She is also a distinguished podcast host for WomenAdvancing, Rebels with a Purpose, and African Tech Conversations. Her contributions to the media highlight her passions in areas like social change and women empowerment. 

Kate brings a wealth of experience and wisdom into creating positive change through entrepreneurship and media.  

Hosted by Justin Lumpkin and Ben Benson. 

CvilleBioHub accelerates the development and commercialization of innovative biotech and medtech solutions that improve human health and well-being by connecting entrepreneurs, scientists and investors, providing access to funding and resources, and advocating for policies that support life sciences. 

Dana Goldsmith is an Entrepreneur In Residence at CvilleBioHub, where her expertise not only guides startups but also bridges them with essential resources. Her journey in Silicon Valley spans over a decade, where she had an instrumental role in six venture-backed startups. Among her most notable achievements was her role as the Director of Business Development for the early-stage AWS team, where her contributions significantly shaped the growth of Amazon. Dana’s first exposure in biotech was in 2009 with the launch of Shoulder Innovations, a medical device company revolutionizing shoulder arthroplasty. Known for her enterprising spirit and passion for entrepreneurship, Dana’s story is a testament to the power of resilience and vision.  

Hosted by Justin Lumpkin and Ben Benson.  

CvilleBioHub accelerates the development and commercialization of innovative biotech and medtech solutions that improve human health and well-being by connecting entrepreneurs, scientists and investors, providing access to funding and resources, and advocating for policies that support life sciences.